The government itself should run and finance US clinical trials of cheap alternatives to price-gouging patented drugs and vaccines. The taxpayer cost of the trials would be peanuts compared to the public’s savings on the drugs.

see @DeanBaker13 econtwitter.net/@DeanBaker13/1